1,633 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AMGN Amgen Inc. $200.81 $129.98B Uptrend
Article Searches
Stock Market News for September 11, 2015 http://www.zacks.com/stock/news/189724/stock-market-news-for-september-11-2015?cid=CS-ZC-FT-189724 Sep 11, 2015 - Benchmarks ended modestly higher on Thursday amid rise in oil prices and uncertainty about the timing of a rate hike
Amgen submits application to FDA for single 420 mg injection of Repatha http://seekingalpha.com/news/2773616-amgen-submits-application-to-fda-for-single-420-mg-injection-of-repatha?source=feed_news_all Sep 11, 2015 - Amgen ([[AMGN]] -0.8%) files an application with the FDA seeking clearance for a single once-per-month 420 mg injection of its cholesterol fighter Repatha
AstraZeneca buys biologics production facility from Amgen http://seekingalpha.com/news/2773126-astrazeneca-buys-biologics-production-facility-from-amgen?source=feed_news_all Sep 11, 2015 - AstraZeneca (AZN) purchases a biologics bulk manufacturing facility from Amgen (AMGN) for an undisclosed sum. The site, located in Boulder, CO, will eventu
The Good News Continues For AstraZeneca http://seekingalpha.com/article/3503946-the-good-news-continues-for-astrazeneca?source=feed_sector_healthcare Sep 11, 2015 - The past ten days has brought continued good fortune for AstraZeneca.Brilinta received approval based on positive outcomes data.The article below builds off my previously posted work on the company.
Amgen Vs. Regeneron In The PCSK9i War, With Comments On Competitive Threats http://seekingalpha.com/article/3501776-amgen-vs-regeneron-in-the-pcsk9i-war-with-comments-on-competitive-threats?source=feed_sector_healthcare Sep 10, 2015 - Now that Amgen and Regeneron-Sanofi have their new cholesterol-lowering drugs on the market, the Street is trying to get a better handle on future profits from these drugs.UBS has moved toward my long
The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA http://www.zacks.com/stock/news/189574/the-zacks-analyst-blog-highlights-amgen-tetraphase-geron-alexion-and-acadia?cid=CS-ZC-FT-189574 Sep 10, 2015 - The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA
Why Buying The Dip In Large Biotechs Is A Good Defense http://seekingalpha.com/article/3499516-why-buying-the-dip-in-large-biotechs-is-a-good-defense?source=feed_sector_healthcare Sep 09, 2015 -
Biotech Stock Roundup: Biosimilar Competition for Amgen, Tetraphase Hit By Disappointing Data http://www.zacks.com/stock/news/189412/biotech-stock-roundup-biosimilar-competition-for-amgen-tetraphase-hit-by-disappointing-data?cid=CS-ZC-FT-189412 Sep 09, 2015 - What will be the impact of biosimilar competition on Amgen's (AMGN) Neupogen now that Zarxio has been launched in the U.S.?
Stock Market News for September 09, 2015 http://www.zacks.com/stock/news/189402/stock-market-news-for-september-09-2015?cid=CS-ZC-FT-189402 Sep 09, 2015 - Benchmarks ended higher on Tuesday after weak Chinese trade data raised hopes that further stimulus measures will be announced to boost its fragile economy
Premarket Biotech Digest: Discovering Cancer Drugs, Biogen P3 AD Drug, A GSK Setback http://seekingalpha.com/article/3498056-premarket-biotech-digest-discovering-cancer-drugs-biogen-p3-ad-drug-a-gsk-setback?source=feed_tag_editors_picks Sep 09, 2015 - I list the hallmarks used to develop cancer drugs.Biogen enrolls first patient in Phase III trial for aducanumab.GlaxoSmithKline’s Relvar/Breo Ellipta Fails to Meet Primary Endpoint.
<<<Page 158>